Who is sponsoring NCT03247946?

NCT03247946 is sponsored by Hadassah Medical Organization.

What drugs are being tested in NCT03247946?

Interventions in NCT03247946: upright head position.

What condition does NCT03247946 study?

NCT03247946 studies Feeding and Eating Disorders.

Is NCT03247946 still recruiting?

NCT03247946 is currently completed. Last updated 16 August 2017.

Last reviewed 2017-08-16 · How we verify

NCT03247946

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Influence of Upright Feeding Position on Pulmonary and Ear Morbidity

Completed NA Last updated 16 August 2017

What this trial tests

NA trial testing upright head position in Feeding and Eating Disorders in 163 participants. Completed in 19 August 2012.

Timeline

13 September 2010

Primary endpoint
19 August 2012

19 August 2012

Quick facts

Lead sponsor	Hadassah Medical Organization
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	163
Start date	13 September 2010
Primary completion	19 August 2012
Estimated completion	19 August 2012
Sites	1 location across Israel

Drugs / interventions tested

upright head position

Conditions studied

Feeding and Eating Disorders — all drugs for Feeding and Eating Disorders →

Sponsor

Hadassah Medical Organization — full company profile →

Who can join

Adults 3 Months to 4 Months, any sex, with Feeding and Eating Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Does upright feeding position of 3 month old infants reduce respiratory and ear morbidity during the following year?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feeding young infants with their head in upright position reduces respiratory and ear morbidity.
Avital A, Donchin M, Springer C, Cohen S, et al · · 2018 · cited 2× · PMID 29700412 · DOI 10.1038/s41598-018-24636-0

Verify or expand the search:

Other recruiting trials for Feeding and Eating Disorders

Currently open trials in the same condition.

NCT06942858 — Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa · NA · recruiting
NCT07348432 — The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes · recruiting
NCT06800807 — Metacognitive Beliefs in Adolescents With Eating and Nutrition Disorders · recruiting
NCT06057415 — Improving Gastrointestinal Function In High-Risk Newborns By Stimulation Of The Enteric Nervous System · NA · recruiting
NCT06514456 — Italian Validation of the State Urge to be Physically Active- Questionnaire (SUPAQ-I) in Patients With Eating Disorders · recruiting

Other Hadassah Medical Organization trials

Trials by the same sponsor.

NCT07430358 — Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence · NA · not yet recruiting
NCT07429019 — Intraoperative Bupivacaine Injection to Reduce Acute and Chronic Pain After TVT/TVT-O Surgery. Randomized Double-Blind T · NA · not yet recruiting
NCT07393568 — The Influence of Patient Use of Artificial Intelligence on Doctor-Patient Interaction and Clinical Outcomes in Endometri · not yet recruiting
NCT07333430 — Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma · Phase 1 · recruiting
NCT06762730 — Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Ind · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03247946 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hadassah Medical Organization
Last refreshed: 16 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03247946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing